Novo Nordisk shares are trading higher Tuesday following approval of its Wegovy GLP-1 pill by the Food and Drug Administration
Trinity Biotech (NASDAQ: TRIB) surged on Tuesday due to a large HIV testing order and balance-sheet restructuring.
VivoPower stock rose after the company announced a shift to focus on its Power-to-X strategy and target high-margin AI computational market.
Reviva Pharmaceuticals said the FDA recommended a second Phase 3 trial for its schizophrenia drug brilaroxazine after a pre-NDA meeting.
Preferred bidder AECOM selected for Scottish Water's multi-billion-dollar Enterprise Alliance to upgrade water & wastewater infrastructure.
Parsons Corporation (NYSE: PSN) stock rose after announcing new transportation and defense contract awards, expanding backlog.
TELA Bio is suing Becton Dickinson for allegedly abusing its monopoly power in the hernia mesh market to limit competition and harm patients.
Neurocrine Biosciences Inc shares fall as Phase 3 study of valbenazine for dyskinetic cerebral palsy did not meet primary endpoints.